Cytek Biosciences, Inc. Common Stock
$5.21
$0.28 (+5.68%)
$4.91Day Range$5.29
Key Statistics
Market Cap
$640.82M
Shares Outstanding
130.0M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jul 23, 2021
Round Lot
100
Locale
US
Trading Data
Day Open
$4.99
Day High
$5.29
Day Low
$4.91
Volume
2.23M
VWAP
$5.12
Prev Close
$4.93
Transactions
--
Acc. Volume
--
About Cytek Biosciences, Inc. Common Stock
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.
LABORATORY ANALYTICAL INSTRUMENTSSIC 3826702 employees47215 LAKEVIEW BOULEVARD, FREMONT, CA, 94538(877) 922-9835IPO Jul 23, 2021US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001831915
- Composite FIGI
- BBG00D36Q0Z7
- Share Class FIGI
- BBG00D36Q103
- Ticker Root
- CTKB
- SIC Code
- 3826
About Cytek Biosciences, Inc. Common Stock (CTKB) Stock
Cytek Biosciences, Inc. Common Stock (CTKB) closed the 2026-09-17 session at $5.21, up 5.68% versus the previous close (+0.28). The stock opened at $4.99 and traded between $4.91 and $5.29 during that session. Session trading volume was 2.2M shares. The volume-weighted average price (VWAP) is $5.12.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.
Cytek Biosciences, Inc. Common Stock has a market capitalization of $640.8 million. The company operates in the LABORATORY ANALYTICAL INSTRUMENTS industry classification. CTKB is listed on the XNAS exchange. The company employs approximately 702 people. Cytek Biosciences, Inc. Common Stock is headquartered in FREMONT, CA. The recorded listing date is 2021-07-23.
On this page you can find market CTKB stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the LABORATORY ANALYTICAL INSTRUMENTS sector.